Search results for Reviews
FiltersOpen Government Canada
Portal
- All portals
- data.gov.au3,649
- Open Government Canada1,600
- data.gov.uk1,230
- Opendatasoft hub1,164
- Humanitarian Data Exchange932
- Data.NSW902
- Socrata network746
- Data.gov Catalog566
- Queensland Government Open Data416
- data.gouv.fr285
- BC Data Catalogue164
- California Open Data134
- data.gov.ie78
- openAFRICA76
- data.overheid.nl36
- GovData Germany33
- DATA.GOV.HK5
1,600 datasets for “Reviews”
- Open Government Canada
Drug and Health Product Submissions Under Review (SUR): New drug submissions under review
Health Canada | Santé CanadaUpdated 1 Sept 2023
Submissions currently under review: New drug submissions
- HTML
- Open Government Canada
Special Review Decision SRD2020-03, Special Review Decision: Metaldehyde
Health Canada | Santé CanadaUpdated 31 May 2023
This document presents the final regulatory decision for the special review of metaldehyde. To comply with this decision …
- HTML
- Open Government Canada
Generic submissions under review
Health Canada | Santé CanadaUpdated 17 Sept 2020
How to access a list of generic drug submissions currently under review.
- HTML
- Open Government Canada
Special Review Decision SRD2022-03, Special Review Decision: Diodofon and Its Associated End-use Products
Health Canada | Santé CanadaUpdated 31 May 2023
This document (Special Review Decision SRD2022-03, Special Review Decision: Diodofon and Its Associated End-use Products) presents …
- HTML
- Open Government Canada
Draft guidance on management of rolling reviews for drug submissions: Applying for rolling review status
Health Canada | Santé CanadaUpdated 1 Sept 2023
To apply for rolling review status for a forthcoming new drug submission (NDS) or supplement to a new …
- HTML
- Open Government Canada
Proposed Special Review Decision PSRD2020-05, Special review for Linuron and its associated end-use products
Health Canada | Santé CanadaUpdated 31 May 2023
… All currently registered pest control products are considered in this special review (Appendix I).
- HTML
- Open Government Canada
Drug and Health Product Submissions Under Review (SUR)
Health Canada | Santé CanadaUpdated 17 Sept 2020
Present the list of new drug submissions (NDSs) that are currently being reviewed.
- HTML
- Open Government Canada
Improving the regulatory review of drugs and devices: Notice to industry - Aligned reviews between Health Canada and health technology assessment organizations
Health Canada | Santé CanadaUpdated 17 Sept 2020
The Health Canada and Health Technology Assessment (HTA) review processes are independent of each other. Aligned reviews project …
- HTML
- Open Government Canada
Universal Periodic Review
Global Affairs Canada | Affaires mondiales CanadaUpdated 13 Aug 2026
How our human rights performance is reviewed under the UN’s Universal Periodic Review.
- HTML
- Open Government Canada
Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility
Health Canada | Santé CanadaUpdated 1 Sept 2023
Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement …
- HTML
- Open Government Canada
Special Review Decision SRD2020-01, Special Review Decision: Acephate
Health Canada | Santé CanadaUpdated 31 May 2023
This document presents the final regulatory decision for the special review of acephate. To comply with this decision …
- HTML
- Open Government Canada
Priority Review of Drug Submissions (Therapeutic Products)
Health Canada | Santé CanadaUpdated 3 Sept 2023
Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review …
- HTML
- Open Government Canada
Special Review Decision SRD2021-02, Special Review Decision: Linuron and Its Associated End-use Products
Health Canada | Santé CanadaUpdated 31 May 2023
This document presents the final regulatory decision for the special review of linuron. A reference list of information …
- HTML
- Open Government Canada
Proposed Special Review Decision PSRD2020-03, Special Review of Pentachlorophenol and Its Associated End-use Products
Health Canada | Santé CanadaUpdated 31 May 2023
… All currently registered pest control products containing pentachlorophenol are considered in this special review (Appendix I of PSRD2020 …
- HTML
- Open Government Canada
Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs
Health Canada | Santé CanadaUpdated 17 Sept 2020
This project will build new review pathways for those drugs shown to meet health care system needs. The …
- HTML
- Open Government Canada
Vehicle Impoundment Reviews
Government of British Columbia | Gouvernment de la Colombie-BritanniqueUpdated 17 Apr 2026
Number of Vehicle Impoundment (VI) reviews conducted by RoadSafetyBC. Breakdown by review outcome, month and year served.
- CSV
- XLSX
- HTML
- Open Government Canada
Child and Youth Death Review and Analysis (CYDRA) and Death Review Committee Recommendations and Responses
Government of Ontario | Gouvernement de l'OntarioUpdated 3 Jun 2026
The datasets on this page provide information about deaths reviewed by Ontario’s death review committees: Domestic Violence …
- CSV
- XLSX
- HTML
- Open Government Canada
Special Review Decision SRD2021-07, Special Review Decision: Iprodione and Its Associated End-use Products
Health Canada | Santé CanadaUpdated 31 May 2023
Iprodione is a contact fungicide registered for commercial uses in Canada. Re-evaluation of iprodione was completed in …
- HTML
- Open Government Canada
Proposed Special Review Decision PSRD2019-04, Special Review of Tetrachlorvinphos and Its Associated End-use Products
Health Canada | Santé CanadaUpdated 29 May 2023
… The aspects of concern for this special review are relevant to human health (potential occupational and residential risks).
- HTML
- Open Government Canada
Proposed Special Review Decision PSRD2021-01, Special review for Iprodione and its associated end-use products
Health Canada | Santé CanadaUpdated 31 May 2023
Before making a final decision on the special review of iprodione, Health Canada will consider all comments received …
- HTML